Severe psoriasis treated with a new macrolide: everolimus.

Frigerio, E; Colombo, M D; Franchi, C; Altomare, A; Garutti, C; Altomare, G F

Frigerio, E; Colombo, M D; Franchi, C; Altomare, A; Garutti, C; Altomare, G F.

Affiliation

Frigerio E; Institute of Dermatology, Ospedale Galeazzi, University of Milan, Via R Galeazzi 4, 20161 Milan, Italy.

Br J Dermatol ; 156(2): 372-4, 2007 Feb.

Article in En | MEDLINE | ID: mdl-17223881

Subject(s)

Cyclosporine/therapeutic use; Immunosuppressive Agents/therapeutic use; Psoriasis/drug therapy; Sirolimus/analogs & derivatives; Drug Synergism; Drug Therapy, Combination; Everolimus; Female; Humans; Middle Aged; Sirolimus/therapeutic use; Treatment Outcome

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Psoriasis / Cyclosporine / Sirolimus / Immunosuppressive Agents Limits: Female / Humans / Middle aged Language: En Journal: Br J Dermatol Year: 2007 Type: Article Affiliation country: Italy

Search on Google

XML

PubMed Links